State of Wisconsin Investment Board’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC
State of Wisconsin Investment Board's LRMR Position: Q1 2026 in Review
State of Wisconsin Investment Board opened a new position in Larimar Therapeutics (LRMR) in Q1 2026: 28,796 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2400 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in LRMR as recently as Q2 2025.
State of Wisconsin Investment Board first reported a position in LRMR in Q3 2018 and has held it in 8 quarters since. The position peaked at $277K in Q3 2018. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.
- State of Wisconsin Investment Board held 28,796 shares of Larimar Therapeutics worth $130K as of Q1 2026.
- Larimar Therapeutics was a new State of Wisconsin Investment Board position in Q1 2026.
- Larimar Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2400 holding.
- State of Wisconsin Investment Board first reported a position in Larimar Therapeutics in Q3 2018 and has held it in 8 quarters since.
- State of Wisconsin Investment Board's Larimar Therapeutics position peaked at $277K in Q3 2018.
- 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.